Last mentioned: Mar 3, 2026
Product Expansion
Anticipated updates to the MX908 handheld platform for forensic use.
Q4 Earnings Release
908 Devices reports top and bottom-line beats.
FY26 Guidance Introduced
Company provides long-term financial targets for the first time.
Bioprocessing Integration
Targeted milestone for ZipChip adoption in major biopharma workflows.
908 Devices (MASS) reported a strong Q4, beating both top and bottom-line estimates and introducing a positive FY26 outlook. The results signal a recovery in the life sciences tools sector, driven by the adoption of point-of-need mass spectrometry in bioprocessing and forensics.
Thor Industries and EVgo have both exceeded analyst expectations for the most recent quarter, signaling robust demand in both the recreational vehicle and electric vehicle infrastructure markets. While Thor reaffirmed its existing long-term targets, EVgo’s introduction of its first FY26 outlook suggests a pivotal shift toward operational maturity and predictable growth.
Thor Industries and EVgo both exceeded top- and bottom-line expectations in their latest quarterly reports, reflecting robust demand for electric mobility and infrastructure. While Thor reaffirmed its FY26 outlook, EVgo introduced its own, signaling confidence in the long-term growth of the EV ecosystem.